Google News – Clinical Trials External News
Life Sciences & Pharma Articles
Google News – Biopharma External News
Sunshine Biopharma Announces Board Vacancy as Dr. Andrew Keller Steps Down After Term Ends - Kalkine Media
Google News – Biopharma External News
Single-Use Comes of Age--What Comes Next? - Genetic Engineering and Biotechnology News
Google News – Pharmaceuticals External News
Positive Phase 3 Survival Results in HER2+ Advanced GEA – Jazz Pharmaceuticals - Oncodaily
Google News – Pharmaceuticals External News
ESC 2026: Evolocumab explores new frontiers in CV disease prevention - Pharmaceutical Technology
Google News – Biopharma External News
Redhill Biopharma Ltd. stock Analysis: Overbought Signals and Key Levels to Watch - The Cryptonomist
Google News – Clinical Trials External News
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor - drugdiscoverytrends.com
Google News – FDA (biotech/pharma) External News
EIT Pharma Raises $35 Million Series A Led By Propel Bio Partners As Lonafarnib NDA Enters FDA Review - Pulse 2.0
Google News – Biopharma External News
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Google News – Biopharma External News
Why biopharma needs asset-light manufacturing models now - EY
Google News – Biopharma External News
RedHill Biopharma (NASDAQ: RDHL) Soars to $1.60 - Monetizes Talicia Stake in $18 Million Cash Deal With Apotex - Investorideas.com
Google News – Pharmaceuticals External News
Is Corvus Pharmaceuticals (CRVS) A Bargain After Its Soquelitinib Data Publication? - simplywall.st
Google News – Biopharma External News
FDA OKs Takeda, Protagonist drug for rare blood cancer - BioPharma Dive
Google News – Biopharma External News
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Draws ‘Buy’ Rating on Lucid-MS Potential - TradingView
Google News – FDA (biotech/pharma) External News